Actinogen Medical Limited (ACW.AX)
AUD 0.03
(-6.9%)
AUD 0.03
(-6.9%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.95 Million | -8.69 Million | -9.51 Million | -1.72 Million | -2.85 Million | -10.49 Million |
| Net Income | -13.04 Million | -10.75 Million | -9.49 Million | -3.91 Million | -5.33 Million | -9.88 Million |
| Depreciation & Amortization | 416.83 Thousand | 405.6 Thousand | 400.66 Thousand | 386.69 Thousand | 412.93 Thousand | 353.5 Thousand |
| Deferred income taxes | - | -2.25 Million | -3.81 Million | 536.73 Thousand | 822.43 Thousand | 1.23 Million |
| Stock-based compensation | 1.3 Million | 1.51 Million | 1.28 Million | 289.28 Thousand | 194.48 Thousand | 127.94 Thousand |
| Change in working capital | -5.23 Million | 131.78 Thousand | -1.69 Million | 1.51 Million | 1.86 Million | -1.35 Million |
| Other non-cash items | -395.28 Thousand | 2.25 Million | 3.79 Million | -536.73 Thousand | -822.43 Thousand | -964.11 Thousand |
| Investing Cash Flow | -8163.00 | -36.59 Thousand | -2937.00 | -6188.00 | -22.76 Thousand | 71.77 Thousand |
| Investments in PPE | -8163.00 | -36.59 Thousand | -2937.00 | -6188.00 | -22.76 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 71.77 Thousand |
| Financing Cash Flow | 17.94 Million | 824.62 Thousand | 12.42 Million | 10.11 Million | 282.25 Thousand | 8.16 Million |
| Debt repayment | -91.69 Thousand | -78.33 Thousand | -71.17 Thousand | -84.1 Thousand | -77.74 Thousand | -560 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.06 Million | -831.28 Thousand | -831.28 Thousand | -715.86 Thousand | - | - |
| Common Stock Issuance | 19.1 Million | 902.95 Thousand | 12.49 Million | 10.19 Million | - | 7.6 Million |
| Other Financing Activities | -91.69 Thousand | 837.95 Thousand | 12.42 Million | 10.11 Million | 360 Thousand | 8.16 Million |
| Accounts receivables | -5.19 Million | -181.67 Thousand | -2.41 Million | 1.48 Million | 1.76 Million | -1.35 Million |
| Accounts payables | -380.04 Thousand | 251.08 Thousand | 688.8 Thousand | 110.29 Thousand | 75.7 Thousand | -215.65 Thousand |
| Inventory | - | - | - | - | - | 210.85 Thousand |
| Other working capital | -38.31 Thousand | 62.36 Thousand | 28.51 Thousand | -84.21 Thousand | 24.7 Thousand | 4792.00 |
| Cash at beginning of period | 8.46 Million | 16.37 Million | 13.42 Million | 5.04 Million | 7.63 Million | 9.89 Million |
| Cash at end of period | 9.45 Million | 8.46 Million | 16.37 Million | 13.42 Million | 5.04 Million | 7.63 Million |
| Capital Expenditure | -8163.00 | -36.59 Thousand | -2937.00 | -6188.00 | -22.76 Thousand | - |
| Effect of forex changes on cash | - | 10.00 | 13.39 Thousand | - | - | - |
| Net cash flow / Change in cash | 990.66 Thousand | -7.91 Million | 2.94 Million | 8.38 Million | -2.59 Million | -2.26 Million |
| Free Cash Flow | -16.95 Million | -8.73 Million | -9.52 Million | -1.73 Million | -2.87 Million | -10.49 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.48 Million | -13.04 Million | -11.55 Million | -10.75 Million | -3.31 Million | -7.43 Million |
| Depreciation & Amortization | 204.86 Thousand | 416.83 Thousand | 211.96 Thousand | 405.6 Thousand | 204.55 Thousand | 201.05 Thousand |
| Deferred income taxes | - | - | - | -2.25 Million | -875.3 Thousand | - |
| Stock-based compensation | 727.15 Thousand | - | 580.26 Thousand | 1.51 Million | 647.87 Thousand | 868.77 Thousand |
| Change in working capital | -5.23 Million | -5.61 Million | - | 131.78 Thousand | -119.3 Thousand | - |
| Other non-cash items | -4.66 Million | 7.7 Million | 5.27 Million | 2.25 Million | -2.52 Million | 4.98 Million |
| Investing Cash Flow | -6663.00 | -8163.00 | -1500.00 | -36.59 Thousand | -23.06 Thousand | -13.53 Thousand |
| Investments in PPE | -6663.00 | -8163.00 | -1500.00 | -36.59 Thousand | -23.06 Thousand | -13.53 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 8.44 Million | 17.94 Million | 9.5 Million | 824.62 Thousand | -39.81 Thousand | 864.44 Thousand |
| Debt repayment | - | - | -42.3 Thousand | -78.33 Thousand | - | -38.51 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -831.28 Thousand | - | - |
| Common Stock Issuance | 8.49 Million | 18.04 Million | 9.54 Million | 902.95 Thousand | - | 902.95 Thousand |
| Other Financing Activities | 8.44 Million | - | 9.54 Million | 837.95 Thousand | -39.81 Thousand | 902.95 Thousand |
| Accounts receivables | -5.19 Million | -5.19 Million | - | -181.67 Thousand | -181.67 Thousand | - |
| Accounts payables | - | -380.04 Thousand | - | 251.08 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -38.31 Thousand | -38.31 Thousand | - | 62.36 Thousand | 62.36 Thousand | - |
| Cash at beginning of period | 11.47 Million | 8.46 Million | 8.46 Million | 16.37 Million | 14.48 Million | 16.37 Million |
| Cash at end of period | 9.45 Million | 9.45 Million | 11.47 Million | 8.46 Million | 8.46 Million | 14.48 Million |
| Capital Expenditure | -6663.00 | -8163.00 | -1500.00 | -36.59 Thousand | -23.06 Thousand | -13.53 Thousand |
| Effect of forex changes on cash | - | - | 8.46 Million | 10.00 | 79.54 Thousand | -79.53 Thousand |
| Net cash flow / Change in cash | -2.02 Million | 990.66 Thousand | 3.01 Million | -7.91 Million | -6.02 Million | -1.88 Million |
| Free Cash Flow | -10.46 Million | -16.95 Million | -6.49 Million | -8.73 Million | -6.06 Million | -2.67 Million |
7919
IMFA
LZAGF
KYKOF
BRITANNIA
YONG